{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:20:48Z","timestamp":1787905248485,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10670-y","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:38:26Z","timestamp":1787899106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Why guideline-directed medical therapy depends on more than guidelines: microeconomics of medication use in heart failure"],"prefix":"10.1007","volume":"31","author":[{"given":"Austin J.","family":"Milton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer J.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Florido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Brann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anees","family":"Daud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Stehlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros G.","family":"Drakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Hanff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"8","key":"10670_CR1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jamacardio.2020.0898","volume":"5","author":"NS Bassi","year":"2020","unstructured":"Bassi NS, Ziaeian B, Yancy CW, Fonarow GC (2020) Association of optimal implementation of sodium-glucose cotransporter 2 inhibitor therapy with outcome for patients with heart failure. JAMA Cardiol 5(8):948\u2013951","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10670_CR2","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.jchf.2023.06.022","volume":"11","author":"SA Swat","year":"2023","unstructured":"Swat SA, Helmkamp LJ, Tietbohl C, Thompson JS, Fitzgerald M, McIlvennan CK et al (2023) Clinical inertia among outpatients with heart failure: application of treatment nonintensification taxonomy to EPIC-HF trial. JACC Heart Fail 11(11):1579\u20131591","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10670_CR3","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.jchf.2024.08.002","volume":"12","author":"SJ Greene","year":"2024","unstructured":"Greene SJ, Bash LD, Tebbs KW, Hancock LN, Barlow SG, Coyle CR (2024) Physician-reported reasons for not initiating guideline-directed medical therapy for heart failure. JACC Heart Fail 12(12):2120\u20132122","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10670_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cardfail.2021.12.017","volume":"28","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Fonarow GC, Opsha Y, Sandhu AT, Sweitzer NK, Warraich HJ (2022) Economic issues in heart failure in the United States. J Card Fail 28(3):453\u2013466","journal-title":"J Card Fail"},{"issue":"16","key":"10670_CR5","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/archinte.164.16.1749","volume":"164","author":"JD Piette","year":"2004","unstructured":"Piette JD, Heisler M, Wagner TH (2004) Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med 164(16):1749\u20131755","journal-title":"Arch Intern Med"},{"issue":"14","key":"10670_CR6","doi-asserted-by":"publisher","first-page":"e022164","DOI":"10.1161\/JAHA.121.022164","volume":"10","author":"SY Wang","year":"2021","unstructured":"Wang SY, Valero-Elizondo J, Ali HJ, Pandey A, Cainzos-Achirica M, Krumholz HM et al (2021) Out-of-pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the United States. J Am Heart Assoc 10(14):e022164","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10670_CR7","first-page":"e011584","volume":"18","author":"BR Rao","year":"2025","unstructured":"Rao BR, Allen LA, Sandhu AT, Dickert NW (2025) Challenges related to out-of-pocket costs in heart failure management. Circulation: Heart Fail 18(3):e011584","journal-title":"Circulation: Heart Fail"},{"issue":"22","key":"10670_CR8","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","volume":"365","author":"NK Choudhry","year":"2011","unstructured":"Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M et al (2011) Full coverage for preventive medications after myocardial infarction. N Engl J Med 365(22):2088\u20132097","journal-title":"N Engl J Med"},{"issue":"5","key":"10670_CR9","first-page":"e006182","volume":"13","author":"AC Fanaroff","year":"2020","unstructured":"Fanaroff AC, Peterson ED, Kaltenbach LA, Anstrom KJ, Fonarow GC, Henry TD et al (2020) Copayment reduction voucher utilization and associations with medication persistence and clinical outcomes. Circulation: Cardiovasc Qual Outcomes 13(5):e006182","journal-title":"Circulation: Cardiovasc Qual Outcomes"},{"issue":"6","key":"10670_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jacc.2023.03.430","volume":"82","author":"H Patolia","year":"2023","unstructured":"Patolia H, Khan MS, Fonarow GC, Butler J, Greene SJ (2023) Implementing guideline-directed medical therapy for heart failure. JACC 82(6):529\u2013543","journal-title":"JACC"},{"issue":"8","key":"10670_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jchf.2024.03.001","volume":"12","author":"SJ Greene","year":"2024","unstructured":"Greene SJ, Ayodele I, Pierce JB, Khan MS, Lewsey SC, Yancy CW et al (2024) Eligibility and projected benefits of rapid initiation of quadruple therapy for newly diagnosed heart failure. JACC Heart Fail 12(8):1365\u20131377","journal-title":"JACC Heart Fail"},{"key":"10670_CR12","doi-asserted-by":"crossref","unstructured":"Cutler D, Zeckhauser R (1999) The Anatomy of Health Insurance. National Bureau of Economic Research, Inc","DOI":"10.3386\/w7176"},{"issue":"11","key":"10670_CR13","first-page":"1102","volume":"20","author":"J Gatwood","year":"2014","unstructured":"Gatwood J, Gibson TB, Chernew ME, Farr AM, Vogtmann E, Fendrick AM (2014) Price elasticity and medication use: cost sharing across multiple clinical conditions. J Manag Care Spec Pharm 20(11):1102\u20131107","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10670_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.18553\/jmcp.2022.21270","volume":"29","author":"N Fusco","year":"2023","unstructured":"Fusco N, Sils B, Graff JS, Kistler K, Ruiz K (2023) Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systematic literature review. J Managed Care Specialty Pharm 29(1):4\u201316","journal-title":"J Managed Care Specialty Pharm"},{"issue":"6","key":"10670_CR15","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/hec.1190","volume":"16","author":"MC Gemmill","year":"2007","unstructured":"Gemmill MC, Costa-Font J, McGuire A (2007) In search of a corrected prescription drug elasticity estimate: a meta-regression approach. Health Econ 16(6):627\u2013643","journal-title":"Health Econ"},{"issue":"1","key":"10670_CR16","doi-asserted-by":"publisher","first-page":"20623","DOI":"10.7448\/IAS.19.1.20623","volume":"19","author":"PM Luz","year":"2016","unstructured":"Luz PM, Girouard MP, Grinsztejn B, Freedberg KA, Veloso VG, Losina E et al (2016) Survival benefits of antiretroviral therapy in Brazil: a model-based analysis. J Int AIDS Soc 19(1):20623","journal-title":"J Int AIDS Soc"},{"issue":"20","key":"10670_CR17","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1016\/j.jacc.2026.02.5113","volume":"87","author":"N Keshvani","year":"2026","unstructured":"Keshvani N, Rizvi Syed K, Jain Anand K, Bustillo-Rubio M, Segar Matthew W, Coellar Juan D et al (2026) Effect of early financial support on medication adherence among low-income patients following heart failure hospitalization. JACC 87(20):2933\u20132936","journal-title":"JACC"},{"issue":"11","key":"10670_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.120.053291","volume":"143","author":"AT Sandhu","year":"2021","unstructured":"Sandhu AT, Heidenreich PA (2021) The affordability of guideline-directed medical therapy. Circulation 143(11):1073\u20131075","journal-title":"Circulation"},{"issue":"1","key":"10670_CR19","first-page":"e011273","volume":"18","author":"NW Dickert","year":"2025","unstructured":"Dickert NW, Speight CD, Balser M, Biermann H, Davis JK, Halpern SD et al (2025) Integrating out-of-pocket costs into shared decision-making for heart failure with reduced ejection fraction: a stepped-wedge trial (POCKET-COST-HF). Circulation: Cardiovasc Qual Outcomes 18(1):e011273","journal-title":"Circulation: Cardiovasc Qual Outcomes"},{"key":"10670_CR20","unstructured":"Survey of Consumer Expectations (2025) In: (FRBNY) FRBoNY, editor"},{"issue":"9","key":"10670_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/jamacardio.2022.2496","volume":"7","author":"T Ahmad","year":"2022","unstructured":"Ahmad T, Desai NR, Yamamoto Y, Biswas A, Ghazi L, Martin M et al (2022) Alerting clinicians to 1-year mortality risk in patients hospitalized with heart failure: The REVEAL-HF randomized clinical trial. JAMA Cardiol 7(9):905\u2013912","journal-title":"JAMA Cardiol"},{"issue":"21","key":"10670_CR22","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1001\/jama.299.21.2533","volume":"299","author":"LA Allen","year":"2008","unstructured":"Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT et al (2008) Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA 299(21):2533\u20132542","journal-title":"JAMA"},{"issue":"11","key":"10670_CR23","first-page":"e004632","volume":"11","author":"J Lewey","year":"2018","unstructured":"Lewey J, Gagne JJ, Franklin J, Lauffenburger JC, Brill G, Choudhry NK (2018) Impact of high deductible health plans on cardiovascular medication adherence and health disparities. Circulation: Cardiovasc Qual Outcomes 11(11):e004632","journal-title":"Circulation: Cardiovasc Qual Outcomes"},{"key":"10670_CR24","unstructured":"Health insurance for all private industry workers 12-month percent change, current dollars. Employment Cost Index (NAICS). Available from: https:\/\/www.bls.gov\/eci\/"},{"issue":"4","key":"10670_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jama.2015.7811","volume":"314","author":"D Altman","year":"2015","unstructured":"Altman D, Frist WH (2015) Medicare and medicaid at 50 years: perspectives of beneficiaries, health care professionals and institutions, and policy makers. JAMA 314(4):384\u2013395","journal-title":"JAMA"},{"issue":"4","key":"10670_CR26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/jama.2015.8421","volume":"314","author":"BD Sommers","year":"2015","unstructured":"Sommers BD, Gunja MZ, Finegold K, Musco T (2015) Changes in self-reported insurance coverage, access to care, and health under the affordable care act. JAMA 314(4):366\u2013374","journal-title":"JAMA"},{"issue":"6","key":"10670_CR27","first-page":"e009753","volume":"16","author":"GY Jiang","year":"2023","unstructured":"Jiang GY, Urwin JW, Wasfy JH (2023) Medicaid expansion under the affordable care act and association with cardiac care: a systematic review. Circulation: Cardiovasc Qual Outcomes 16(6):e009753","journal-title":"Circulation: Cardiovasc Qual Outcomes"},{"key":"10670_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jhealeco.2018.11.002","volume":"63","author":"A Ghosh","year":"2019","unstructured":"Ghosh A, Simon K, Sommers BD (2019) The effect of health insurance on prescription drug use among low-income adults: evidence from recent medicaid expansions. J Health Econ 63:64\u201380","journal-title":"J Health Econ"},{"issue":"10","key":"10670_CR29","doi-asserted-by":"publisher","first-page":"e2441915","DOI":"10.1001\/jamanetworkopen.2024.41915","volume":"7","author":"E Trish","year":"2024","unstructured":"Trish E, Van Nuys K, Wu J, Desai NR (2024) The inflation reduction act and patient costs for drugs to treat heart failure. JAMA Netw Open 7(10):e2441915","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10670_CR30","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jchf.2016.02.007","volume":"4","author":"JB King","year":"2016","unstructured":"King JB, Shah RU, Bress AP, Nelson RE, Bellows BK (2016) Cost-effectiveness of sacubitril-valsartan combination therapy compared with enalapril for the treatment of heart failure with reduced ejection fraction. JACC Heart Fail 4(5):392\u2013402","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10670_CR31","doi-asserted-by":"publisher","first-page":"e032279","DOI":"10.1161\/JAHA.123.032279","volume":"13","author":"AS Bhatt","year":"2024","unstructured":"Bhatt AS, Vaduganathan M, Claggett BL, Kulac IJ, Anand IS, Desai AS et al (2024) Cost effectiveness of dapagliflozin for heart failure across the spectrum of ejection fraction: an economic evaluation based on pooled, individual participant data from the DELIVER and DAPA-HF trials. J Am Heart Association 13(5):e032279","journal-title":"J Am Heart Association"},{"issue":"15","key":"10670_CR32","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.119.045093","volume":"141","author":"DS Kazi","year":"2020","unstructured":"Kazi DS, Bellows BK, Baron SJ, Shen C, Cohen DJ, Spertus JA et al (2020) Cost-effectiveness of tafamidis therapy for transthyretin amyloid cardiomyopathy. Circulation 141(15):1214\u20131224","journal-title":"Circulation"},{"issue":"9","key":"10670_CR33","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/clc.23664","volume":"44","author":"PA McCullough","year":"2021","unstructured":"McCullough PA, Mehta HS, Barker CM, Van Houten J, Mollenkopf S, Gunnarsson C et al (2021) Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction. Clin Cardiol 44(9):1192\u20131198","journal-title":"Clin Cardiol"},{"issue":"5","key":"10670_CR34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/clc.22260","volume":"37","author":"J Voigt","year":"2014","unstructured":"Voigt J, Sasha John M, Taylor A, Krucoff M, Reynolds MR, Michael Gibson C (2014) A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States. Clin Cardiol 37(5):312\u2013321","journal-title":"Clin Cardiol"},{"key":"10670_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ahj.2018.08.006","volume":"206","author":"KA Schulman","year":"2018","unstructured":"Schulman KA, Dabora M (2018) The relationship between pharmacy benefit managers (PBMs) and the cost of therapies in the US pharmaceutical market: A policy primer for clinicians. Am Heart J 206:113\u2013122","journal-title":"Am Heart J"},{"issue":"20","key":"10670_CR36","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.jacc.2021.08.064","volume":"78","author":"VN Rao","year":"2021","unstructured":"Rao VN, Murray E, Butler J, Cooper LB, Cox ZL, Fiuzat M et al (2021) In-hospital initiation of sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction. JACC 78(20):2004\u20132012","journal-title":"JACC"},{"key":"10670_CR37","unstructured":"Cubanski J (2025) [Internet]: KFF 2025. Available from: https:\/\/www.kff.org\/medicare\/faqs-about-the-inflation-reduction-acts-medicare-drug-price-negotiation-program\/?entry=table-of-contents-how-many-and-which-types-of-drugs-qualified-for-price-negotiation-for-2027"},{"issue":"11","key":"10670_CR38","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1161\/HYPERTENSIONAHA.124.23509","volume":"81","author":"JA Jacobs","year":"2024","unstructured":"Jacobs JA, Rodgers A, Bellows BK, Hernandez I, Wang N, Derington CG et al (2024) Use and cost patterns of antihypertensive medications in the United States From 1996 to 2021. Hypertension 81(11):2307\u20132317","journal-title":"Hypertension"},{"issue":"10","key":"10670_CR39","doi-asserted-by":"publisher","first-page":"e233660","DOI":"10.1001\/jamahealthforum.2023.3660","volume":"4","author":"TJ Mattingly","year":"2023","unstructured":"Mattingly TJ, II, Ben-Umeh KC, Bai G, Anderson GF (2023) Pharmacy benefit manager pricing and spread pricing for high-utilization generic drugs. JAMA Health Forum 4(10):e233660\u2013e","journal-title":"JAMA Health Forum"},{"issue":"7","key":"10670_CR40","first-page":"e006564","volume":"13","author":"MA Psotka","year":"2020","unstructured":"Psotka MA, Singletary EA, Bleser WK, Roiland RA, Hamilton Lopez M, Saunders RS et al (2020) Streamlining and reimagining prior authorization under value-based contracts: a call to action from the value in healthcare initiative\u2019s prior authorization learning collaborative. Circulation: Cardiovasc Qual Outcomes 13(7):e006564","journal-title":"Circulation: Cardiovasc Qual Outcomes"},{"issue":"2","key":"10670_CR41","doi-asserted-by":"publisher","first-page":"e220320","DOI":"10.1001\/jamanetworkopen.2022.0320","volume":"5","author":"H Fang","year":"2022","unstructured":"Fang H, Frean M, Sylwestrzak G, Ukert B (2022) Trends in disenrollment and reenrollment within US commercial health insurance plans, 2006\u20132018. JAMA Netw Open 5(2):e220320\u2013e","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10670_CR42","doi-asserted-by":"publisher","first-page":"102583","DOI":"10.1016\/j.jacadv.2025.102583","volume":"5","author":"A Mukhopadhyay","year":"2026","unstructured":"Mukhopadhyay A, Adhikari S, Li X, Kazi DS, Berman AN, Kronish I et al (2026) Prior authorization requirements and prescription fill patterns among patients with heart failure. JACC Adv 5(2):102583","journal-title":"JACC Adv"},{"issue":"4","key":"10670_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jamacardio.2023.5627","volume":"9","author":"AB Tang","year":"2024","unstructured":"Tang AB, Brownell NK, Roberts JS, Haidar A, Osuna-Garcia A, Cho DJ et al (2024) Interventions for optimization of guideline-directed medical therapy: a systematic review. JAMA Cardiol 9(4):397\u2013404","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10670_CR44","first-page":"83","volume":"31","author":"B Perry","year":"2025","unstructured":"Perry B, Jakab J, Robinson B, McElhaney E, Fallon J, Geyer K (2025) Implementation of an adherence pharmacy referral protocol for patients taking sacubitril\/valsartan. J Manag Care Spec Pharm 31(1):83\u201387","journal-title":"J Manag Care Spec Pharm"},{"key":"10670_CR45","unstructured":"10 states have tackled prior authorization (2024) so far in 2024 [press release], vol 19. American Medical Association"},{"key":"10670_CR46","unstructured":"States Lead on (2025) Prior Authorization Reform [press release]"},{"key":"10670_CR47","unstructured":"Support for Reducing Medically Unnecessary (2025) Delays in Care Act (H.R. 2433) [press release]"},{"issue":"9","key":"10670_CR48","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jacc.2017.07.727","volume":"70","author":"H Wilson","year":"2017","unstructured":"Wilson H, Shor R (2017) ACC Tackling Prior Authorization. JACC 70(9):1193\u20131195","journal-title":"JACC"},{"key":"10670_CR49","unstructured":"Text, - S.1816\u2013119th Congress (2025\u20132026): Improving Seniors\u2019 Timely Access to Care Act of 2025"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10670-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10670-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10670-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:02:54Z","timestamp":1787904174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10670-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10670"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10670-y","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"98"}}